146 results
Page 4 of 8
8-K
EX-99.1
nrs2w
13 Jan 20
Results of Operations and Financial Condition
6:03am
8-K
EX-99.1
bj56n4hugmety34 po
19 Dec 19
Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
8:31am
8-K
EX-99.2
giqv7
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-1.1
o64nuypzo9jsqb
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-99.1
wgn9p6axhgvp
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
424B5
13z 4pp4kgrm
5 Dec 19
Prospectus supplement for primary offering
4:06pm
424B5
taua6e1bm6z0e98xex
4 Dec 19
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
oi6uph05ho
29 Mar 19
Millendo Reports Full Year 2018 Operating and Financial Results
7:20am
8-K
EX-99.1
8f28l
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
EX-99.1
jw52lk
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
8-K
EX-10.4
xvlig2d9gq
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.2
zzfzbpreevvvk
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.3
jkamsar
6 Dec 18
Entry into a Material Definitive Agreement
6:18am